Amble vs HealthOn
An in-depth comparison of two leading GLP-1 Providers
WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. Learn more
Amble
Best for mainstream telehealth GLP-1 accessStarting at $179/mo
HealthOn
Best for compounded GLP-1 accessStarting at $155/mo
Side-by-Side Comparison
| Feature | Amble | HealthOn |
|---|---|---|
| Overall Score | ✓7.4/10 | 7.0/10 |
| Starting Price | $179/mo | ✓$155/mo |
| Editorial Rating | ✓3.7 ★ /5 | 3.5 ★ /5 |
| Features | ✓3 features | 2 features |
| States Available | ✓50 | 0 |
| Compounded | ✓ Yes | ✓ Yes |
| Brand Name | — | — |
| FSA/HSA Accepted | — | — |
| FDA Warnings | None | None |
Pros & Cons
Amble
Pros
- ✓Both semaglutide and tirzepatide available
- ✓Compounded GLP-1 access
Cons
- ✗Limited public information on program details
HealthOn
Pros
- ✓Both compounded semaglutide and tirzepatide available
- ✓Competitive starting price at $155/mo
Cons
- ✗No visible LegitScript certification or PCAB accreditation
- ✗State availability not publicly disclosed
- ✗Pricing details beyond starting price not visible
Our Verdict
Amble edges out HealthOn with a higher overall score of 7.4/10 and is particularly strong for mainstream telehealth GLP-1 access. HealthOn remains a solid alternative, especially if you're looking for compounded GLP-1 access.
Wegovy®, Ozempic®, and Rybelsus® are trademarks of Novo Nordisk A/S. Mounjaro® and Zepbound® are trademarks of Eli Lilly and Company. All other product names and trademarks referenced on this page belong to their respective owners. WeightLossRankings.org is not affiliated with any pharmaceutical manufacturer. See trademark disclaimer.